Nexus Lifecare Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 05-12-2024
- Paid Up Capital ₹ 4.05 M
as on 05-12-2024
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.66 Cr
as on 05-12-2024
- Satisfied Charges ₹ 6.46 M
as on 05-12-2024
- Revenue -2.93%
(FY 2021)
- Profit 18.15%
(FY 2021)
- Ebitda -118.59%
(FY 2021)
- Net Worth 16.43%
(FY 2021)
- Total Assets 18.33%
(FY 2021)
About Nexus Lifecare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.05 M.
The company currently has active open charges totaling ₹8.66 Cr. The company has closed loans amounting to ₹6.46 M, as per Ministry of Corporate Affairs (MCA) records.
Manish Satia and Jeet Champalal serve as directors at the Company.
- CIN/LLPIN
U85100MH2008PTC187360
- Company No.
187360
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Oct 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nexus Lifecare Private Limited offer?
Nexus Lifecare Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Cardiovascular Drugs & Medication, Immunosuppressive Drugs, Common Disease Medicines, Skin Lightening Drugs, Anti Infective Drugs & Medicines, Antifungal Injection, Tablet & Syrup, Antibiotic Injection, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Nexus Lifecare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Satia  | Director | 08-Oct-2008 | Current |
| Jeet Champalal | Director | 08-Oct-2008 | Current |
Financial Performance of Nexus Lifecare.
Nexus Lifecare Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 2.93% decrease. The company also saw a substantial improvement in profitability, with a 18.15% increase in profit. The company's net worth Soared by an impressive increase of 16.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nexus Lifecare?
In 2021, Nexus Lifecare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nissor Pharmaceuticals LimitedActive 9 years 8 monthsManish Satia and Jeet Champalal are mutual person
Just Creativo Private LimitedActive 2 years 8 monthsManish Satia and Jeet Champalal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Sep 2018 | ₹6.04 Cr | Open |
Idbi Bank Limited Creation Date: 31 Mar 2017 | ₹1.20 Cr | Open |
Idbi Bank Limited Creation Date: 31 Mar 2017 | ₹1.42 Cr | Open |
How Many Employees Work at Nexus Lifecare?
Unlock and access historical data on people associated with Nexus Lifecare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nexus Lifecare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexus Lifecare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
